Bacoside A
CAS: 11028-00-5
Ref. TM-T3426
1mg | 181,00 € | ||
5mg | 448,00 € | ||
10mg | 642,00 € | ||
25mg | 1.002,00 € | ||
50mg | 1.382,00 € | ||
100mg | 1.827,00 € |
Informação sobre produto
- (5R,8R,9S,10S,13R,14R,17S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-10-(hydroxymethyl)-4,4,8,14-tetramethyl-1,2,3,5,6,7,9,11,12,13,15,17-dodecahydrocyclopenta[a]phenanthren-16-one
- 3-[(O-α-<span class="text-smallcaps">L</smallcap>-Arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxydammar-24-en-16-one
- Dammar-24-en-16-one, 3-[(O-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
- Dammar-24-en-16-one, 3-[(α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-O-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro. It exerts cytoprotective efficacy by attenuation of ROS generated through oxidative stress by an increase in the concentration of antioxidant enzymes and sustain membrane integrity which leads to restoring the damage caused by tBHP. Bacoside A can able to inhibit the progression of Experimental Autoimmune Encephalomyelitis (EAE) may be by the inhibition of inflammatory cytokines and chemokine evolved during active EAE. Bacoside A also has vasorelaxation.
Propriedades químicas
Consulta técnica sobre: TM-T3426 Bacoside A
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.